Xu J - Search Results

1

Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease.

Kahaly GJ, Dolman PJ, Wolf J, Giers BC, Elflein HM, Jain AP, Srinivasan A, Hadjiiski L, Jordan D, Bradley EA, Stan MN, Eckstein A, Pitz S, Vorländer C, Wester ST, Nguyen J, Tucker N, Sales-Sanz M, Feldon SE, Nelson CC, Hardy I, Abia-Serrano M, Tedeschi P, Janes JM, Xu J, Vue P, Macias WL, Douglas RS. Kahaly GJ, et al. Among authors: xu j. J Clin Endocrinol Metab. 2023 Nov 17;108(12):3122-3134. doi: 10.1210/clinem/dgad381. J Clin Endocrinol Metab. 2023. PMID: 37390454 Free PMC article. Clinical Trial.

2

"Indeterminate" UroVysion Fluorescence In Situ Hybridization Results.

Xu J, Westfall DE, Lopategui JR. Xu J, et al. Am J Clin Pathol. 2021 Aug 4;156(3):427-432. doi: 10.1093/ajcp/aqaa254. Am J Clin Pathol. 2021. PMID: 33693491

3

Primary cutaneous small/medium CD4⁺ T-cell lymphoproliferative disorder.

Xu J, Huang Q. Xu J, et al. Blood. 2018 Aug 16;132(7):765. doi: 10.1182/blood-2018-05-850941. Blood. 2018. PMID: 30115635 Free article. No abstract available.

4

U.S. State Life Tables, 2021.

Arias E, Xu J, Tejada-Vera B, Bastian B. Arias E, et al. Among authors: xu j. Natl Vital Stat Rep. 2024 Aug 21;(7). doi: 10.15620/cdc/157499. Natl Vital Stat Rep. 2024. PMID: 39412855

5

Construction of a comprehensive meteorological risk index for wheat Fusarium head blight prediction based on more than a half-century of monitoring data.

Xu M, Xu Y, Xu J, Xu M, Yang R, Liu X. Xu M, et al. Among authors: xu j. Plant Dis. 2024 Oct 16. doi: 10.1094/PDIS-05-24-1095-RE. Online ahead of print. Plant Dis. 2024. PMID: 39412845

6

Hollow Calcium/Copper Bimetallic Amplifier for Cuproptosis/Paraptosis/Apoptosis Cancer Therapy via Cascade Reinforcement of Endoplasmic Reticulum Stress and Mitochondrial Dysfunction.

Xu W, Suo A, Aldai AJM, Wang Y, Fan J, Xia Y, Xu J, Chen Z, Zhao H, Zhang M, Qian J. Xu W, et al. Among authors: xu j. ACS Nano. 2024 Oct 16. doi: 10.1021/acsnano.4c11455. Online ahead of print. ACS Nano. 2024. PMID: 39412236

7

BIN2 inhibition suppress ovarian cancer progression meanwhile protect ovarian function through downregulating HDAC1 and RPS6 phosphorylation respectively.

Li CR, Xie SY, Zhang SP, Yang YJ, Yang LL, Cao Y, Wang LL, Zhu FY, Wang RL, Yang ZX, Cui CC, Li YR, Xu JN, Yue F, Tian PZ, Wang Q, Yao HJ, Guan YC, Zhang SD, Ying XY, Zhang D, Zhang CL. Li CR, et al. Among authors: xu jn. Clin Transl Med. 2024 Oct;14(10):e70051. doi: 10.1002/ctm2.70051. Clin Transl Med. 2024. PMID: 39412213 No abstract available.

8

Simultaneous Determination of the Position and Cis-Trans Configuration of Lipid C═C Bonds via Asymmetric Derivatization and Ion Mobility-Mass Spectrometry.

Tang S, Wang H, Zhang H, Zhang M, Xu J, Yang C, Chen X, Guo X. Tang S, et al. Among authors: xu j. J Am Chem Soc. 2024 Oct 16. doi: 10.1021/jacs.4c08980. Online ahead of print. J Am Chem Soc. 2024. PMID: 39412160

9

Regulation of Curcumin on Follicle Initiation Rate in Diminished Ovarian Reserve.

Li W, Xu J, Wang J, Zhang J, Deng D. Li W, et al. Among authors: xu j. Comb Chem High Throughput Screen. 2024 Oct 14. doi: 10.2174/0113862073327087240926065629. Online ahead of print. Comb Chem High Throughput Screen. 2024. PMID: 39411943

10

Improving Colorectal Cancer Screening via Mailed Fecal Immunochemical Testing in a Veterans Affairs Health System.

Xu J, Kravetz J, Spelman J, Roy K, Lilly V, Cosentino D, Ruser C. Xu J, et al. Fed Pract. 2024 Aug;41(Suppl 3):S39-S42. doi: 10.12788/fp.0496. Epub 2024 Aug 15. Fed Pract. 2024. PMID: 39411394 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

65,283 results

Search Page